Eyepoint Pharmaceuticals (EYPT) had the highest return between March 23, 2023 and April 30, 2023 by a small-cap US stock, returning 159.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Eyepoint Pharmaceuticals (EYPT) | 3/23/2023 - 4/30/2023 | 159.5% |
National CineMedia (NCMI) | 3/23/2023 - 4/30/2023 | 138.75% |
Pulse Biosciences (PLSE) | 3/23/2023 - 4/30/2023 | 120.77% |
Y mAbs Therapeutics (YMAB) | 3/23/2023 - 4/30/2023 | 110.92% |
GDEV (GDEV) | 3/23/2023 - 4/30/2023 | 100% |
Trevi Therapeutics (TRVI) | 3/23/2023 - 4/30/2023 | 94.35% |
American Coastal Insurance (ACIC) | 3/23/2023 - 4/30/2023 | 84.38% |
Arcturus Therapeutics (ARCT) | 3/23/2023 - 4/30/2023 | 78.42% |
Brookdale Senior Living (BKD) | 3/23/2023 - 4/30/2023 | 76.54% |
Xeris Pharmaceuticals (XERS) | 3/23/2023 - 4/30/2023 | 71.21% |
Amprius Technologies (AMPX) | 3/23/2023 - 4/30/2023 | 67.8% |
Phathom Pharmaceuticals (PHAT) | 3/23/2023 - 4/30/2023 | 65.89% |
Tourmaline Bio (TRML) | 3/23/2023 - 4/30/2023 | 62.71% |
Magnera Corp placeholder (MAGN) | 3/23/2023 - 4/30/2023 | 62.59% |
Getty Images (GETY) | 3/23/2023 - 4/30/2023 | 60.75% |
Cimpress (CMPR) | 3/23/2023 - 4/30/2023 | 60.49% |
Sana Biotechnology (SANA) | 3/23/2023 - 4/30/2023 | 59.82% |
Aquestive Therapeutics (AQST) | 3/23/2023 - 4/30/2023 | 59.52% |
ATAI Life Sciences (ATAI) | 3/23/2023 - 4/30/2023 | 59.17% |
P3 Health Partners (PIII) | 3/23/2023 - 4/30/2023 | 55.18% |
Corvus Pharmaceuticals (CRVS) | 3/23/2023 - 4/30/2023 | 54.29% |
Mereo BioPharma Group PLC ADR (MREO) | 3/23/2023 - 4/30/2023 | 54.12% |
Collective Mining (CNL) | 3/23/2023 - 4/30/2023 | 53.85% |
Bright Minds Biosciences (DRUG) | 3/23/2023 - 4/30/2023 | 49.76% |
CorMedix (CRMD) | 3/23/2023 - 4/30/2023 | 49.7% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
